Phase 1b clinical site start-up and regulatory activities in Australia underway to support the global registrational program - HUNTSVILLE, AL, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Serina Therapeutics, ...
The State of Trust Report by Vanta, which surveyed IT and business leaders in the U.S., U.K., and Australia in July 2025, ...
Laureate Education (NASDAQ:LAUR) delivers global higher education programs as part of discussions linked to the nasdaq top ...
Neutral overview of aerospace and defense sector operations highlighting manufacturing structure, reporting practices, and ...
Announces divestiture plan for Hawthorne Unveils new multi-year share repurchase program to commence in late 2026 MARYSVILLE, Ohio, Jan. 28, 2026 (GLOBE NEWSWIRE) -- The Scotts Miracle-Gro Company (NY ...
Astrana Health shares fell 22% after CMS proposed modest Medicare Advantage growth, but analyst says sell-off looks overdone ...
The Institute for Museum and Library Services (IMLS) joins the public In solemn commemoration of International Holocaust ...
Nicki Minaj is listed as one of several speakers set to appear at an upcoming Treasury Department event to discuss Trump ...
Specialty-specific clinical documentation requires more than a generic, automated note taker to truly improve the charting process. Today, Nextech - an award-winning technology partner for specialty ...
BELLEVUE, WA / ACCESS Newswire / January 27, 2026 / OSR Holdings, Inc. (NASDAQ:OSRH) today announced the official closing of its acquisition of Woori IO, the reaffirmation of long-term equity alignmen ...
At the heart of Bionxt's clinical strategy is a novel sublingual, orally dissolving film (ODF) formulation of the drug Cladribin. Cladribin is already an approved tablet therapy for Multiple Sclerosis ...
The CMS proposed modest payment growth for Medicare Advantage in 2027 and emphasized sustainability, accuracy, and simplicity.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results